【目的】 对比分析腹膜外与经腹腔开放性根治性膀胱切除回肠膀胱术的临床应用效果?【方法】 回顾性分析83例肌层浸润性膀胱癌患者的临床资料?其中45例为经腹膜外入路行根治性膀胱切除回肠膀胱术(腹膜外组),38例为经腹腔入路(经腹腔组)?【结果】 腹膜外组平均手术时间240 min,平均出血量300 mL,术后肠道排气时间48.6 h,离床下地时间4.5 d,术后住院时间12.5 d,均明显低于经腹腔组,差异均有统计学意义(P 0.05)?
doaj
[Analysis of setup errors and their correlation with clinical factors in image-guided radiotherapy for prostate cancer using different immobilization devices]. [PDF]
Guo X +5 more
europepmc +1 more source
[Effectiveness evaluation of three-dimensional printed customized hemi-pelvic prosthesis for pelvic reconstruction after resection of massive pelvic tumor]. [PDF]
Su Y, Gao C, Wu H, Sun Z, Yan W.
europepmc +1 more source
[Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder]. [PDF]
Huang W +8 more
europepmc +1 more source
在世界范围内,膀胱癌诊出率居于恶性肿瘤中的第九位,2022年在全球范围内约有61万个新发病例和22万个死亡病例[1]。以手术切除为主,放化疗和免疫治疗相结合的策略在膀胱癌的治疗上取得了很大成功,但晚期膀胱癌患者的预后仍然较差[2]。因此,我们应该积极寻找和评估新的用于诊断及预后监测的生物标志物。
李婷淼, 薛菲, 岳斯琦, 何成彦
doaj
Analyzing Online Search Trends for Kidney, Prostate, and Bladder Cancers in China: Infodemiology Study Using Baidu Search Data (2011-2023). [PDF]
Lin S +6 more
europepmc +1 more source
[High expression of miR-204-5p promotes malignant behaviors of bladder cancer cells by negatively regulating RAB22A]. [PDF]
Li L +7 more
europepmc +1 more source
[Research Progress and Applications of ZDHHC-mediated Protein Palmitoylation in the Development and Immune Escape of Non-small Cell Lung Cancer]. [PDF]
Chen W +5 more
europepmc +1 more source
[Pentosan polysulfate alleviates cyclophosphamide-induced interstitial cystitis/bladder pain syndrome in mice by modulating gut microbiota and bile acid metabolism]. [PDF]
Zhu Y, Zhu Z, Wu P.
europepmc +1 more source
[Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder]. [PDF]
Huang S +8 more
europepmc +1 more source

